Showing results (871-880 of 1,516) with videos related to

Sort By:
Pageof 152
Infection|August 31, 2021
COVID-19 in young and middle-aged adults: predictors of poor outcome and clinical differencesEva Tabernero, Luis A Ruiz, Pedro P España, et al.
Nature Reviews. Clinical Oncology|April 5, 2017
Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challengesConor A Bradley, Manuel Salto-Tellez, Pierre Laurent-Puig, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2013
HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximabF Sclafani, A Roy, D Cunningham, et al.
European Journal of Cancer (Oxford, England : 1990)|September 22, 2018
Cancer Core Europe: A European cancer research alliance realizing a research infrastructure with critical mass and programmatic approach to cure cancer in the 21st centuryFabien Calvo, Giovanni Apolone, Michael Baumann, et al.
Expert Opinion on Investigational Drugs|May 22, 2024
Epidermal growth factor receptor antagonists in colorectal cancer: emerging strategies for precision therapyNadia Saoudi González, Paola Valeria Marchese, Iosune Baraibar, et al.
Journal of Human Evolution|June 18, 2017
Three-dimensional morphometrics of thoracic vertebrae in Neandertals and the fossil evidence from El Sidrón (Asturias, Northern Spain)Markus Bastir, Daniel García Martínez, Luis Rios, et al.
Respiratory Medicine|August 7, 2025
Non-tuberculous micobacteria in the elderly. Multicentric studyI Gonzalez-Munoz, M V Leal Arranz, J A Garcia Fuentes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2017
HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaManish A Shah, Rui-Hua Xu, Yung-Jue Bang, et al.
Clinical Colorectal Cancer|June 8, 2007
Phase II study of trabectedin in pretreated patients with advanced colorectal cancerLuis Paz-Ares, Fernando Rivera-Herreros, Eduardo Díaz-Rubio, et al.
Archivos De Neurobiologia|November 1, 1991
[Effect of a controlled low-protein diet on the pharmacological response to levodopa and on the plasma levels of L-dopa and amino acids in patients with Parkinson's disease]G Sanchís, M A Mena, R Martín del Río, et al.
Pageof 152